Roche Profit Dented by Strong Swiss Franc

Swiss drugmaker Roche reported 5% fall in full-year net income as the strong Swiss franc countered gains by the company’s diagnostics activities and all-important breast cancer business.

from WSJ.com: US Business http://ift.tt/1ZUt73V
via IFTTT